NEW YORK, Dec. 9 - Gen-Probe and the Tosoh Bioscience unit of Tokyo-based Tosoh Corp. said today that they have cross-licensed intellectual property covering certain nucleic acid testing technologies.
Tosoh will receive non-exclusive rights to Gen-Probe's transcription-mediated amplification (TMA) and ribosomal RNA technologies in exchange for two payments in 2004. Tosoh will also pay Gen-Probe royalties on worldwide sales of products based on the licensed Gen-Probe technologies.
Gen-Probe will gain access, in exchange for royalties, to Tosoh's patented TRC (transcription reverse-transcription concerted) amplification and INAF (intercalation activating fluorescence) detection technologies for use with real-time TMA.
The licenses are effective Jan. 1, 2004.